Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03834506
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,030
Not applicableUnknownNCT01163058
What this trial is testing

Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Istituto Clinico Humanitas 300
Testing effectiveness (Phase 2)Ended earlyNCT01732549
What this trial is testing

A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Ipsen 144
Early research (Phase 1)Study completedNCT03835533
What this trial is testing

Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Parker Institute for Cancer Immunotherapy 43
Early research (Phase 1)Ended earlyNCT04677855
What this trial is testing

Study of PCUR-101 in Combination With ADT in Patients With mCRPC

Who this might be right for
Prostate Cancer
Pellficure Pharmaceuticals, Inc 7
Large-scale testing (Phase 3)Study completedNCT03511664
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Endocyte 861
Testing effectiveness (Phase 2)Ended earlyNCT03770455
What this trial is testing

Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Jodi Layton, MD 8
Testing effectiveness (Phase 2)Study completedNCT01498978
What this trial is testing

Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
OHSU Knight Cancer Institute 10
Testing effectiveness (Phase 2)Ended earlyNCT05538624
What this trial is testing

Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Who this might be right for
Neoplasm, OvarianFallopian Tube CancerPrimary Peritoneal Cavity Cancer+5 more
Avenge Bio, Inc 14
Early research (Phase 1)Study completedNCT00001570
What this trial is testing

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

Who this might be right for
Kidney NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 46
Early research (Phase 1)Looking for participantsNCT06705686
What this trial is testing

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-resistant Prostate Carcinoma
TechnoGenesys, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07549256
What this trial is testing

Cannabidiol for Pain Relief of Patients With End-stage mCRPC

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Regionshospital Nordjylland 58
Early research (Phase 1)Study completedNCT02913196
What this trial is testing

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Who this might be right for
Prostate Cancer Metastatic
Weill Medical College of Cornell University 16
Testing effectiveness (Phase 2)Looking for participantsNCT04704505
What this trial is testing

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate AdenocarcinomaMetastatic Prostate AdenocarcinomaCastration-resistant
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT05547061
What this trial is testing

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy

Who this might be right for
Prostate CancermCRPC
Cellbion Co., Ltd. 91
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06182761
What this trial is testing

Sunvozertinib Combined With Anlotinib in Local Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Zhongshan Hospital 45
Large-scale testing (Phase 3)WithdrawnNCT03800784
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Active Not RecruitingNCT04655365
What this trial is testing

Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 50
Testing effectiveness (Phase 2)Ended earlyNCT03311334
What this trial is testing

DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Urothelial CarcinomaPrimary Peritoneal Cancer+3 more
Sumitomo Pharma America, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT02958852
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Lund University Hospital 126
Next Page